NM_012479.4:c.87+3507C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_012479.4(YWHAG):c.87+3507C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.205 in 152,076 control chromosomes in the GnomAD database, including 3,432 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.21 ( 3432 hom., cov: 33)
Consequence
YWHAG
NM_012479.4 intron
NM_012479.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.14
Publications
12 publications found
Genes affected
YWHAG (HGNC:12852): (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma) This gene product belongs to the 14-3-3 family of proteins which mediate signal transduction by binding to phosphoserine-containing proteins. This highly conserved protein family is found in both plants and mammals, and this protein is 100% identical to the rat ortholog. It is induced by growth factors in human vascular smooth muscle cells, and is also highly expressed in skeletal and heart muscles, suggesting an important role for this protein in muscle tissue. It has been shown to interact with RAF1 and protein kinase C, proteins involved in various signal transduction pathways. [provided by RefSeq, Jul 2008]
YWHAG Gene-Disease associations (from GenCC):
- developmental and epileptic encephalopathy, 56Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Illumina, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.317 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.205 AC: 31185AN: 151958Hom.: 3430 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
31185
AN:
151958
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.205 AC: 31195AN: 152076Hom.: 3432 Cov.: 33 AF XY: 0.207 AC XY: 15371AN XY: 74314 show subpopulations
GnomAD4 genome
AF:
AC:
31195
AN:
152076
Hom.:
Cov.:
33
AF XY:
AC XY:
15371
AN XY:
74314
show subpopulations
African (AFR)
AF:
AC:
6861
AN:
41512
American (AMR)
AF:
AC:
3847
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
887
AN:
3470
East Asian (EAS)
AF:
AC:
1710
AN:
5176
South Asian (SAS)
AF:
AC:
1325
AN:
4814
European-Finnish (FIN)
AF:
AC:
1934
AN:
10534
Middle Eastern (MID)
AF:
AC:
59
AN:
294
European-Non Finnish (NFE)
AF:
AC:
14015
AN:
67986
Other (OTH)
AF:
AC:
426
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1265
2531
3796
5062
6327
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
338
676
1014
1352
1690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1036
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.